HASI Announces 2023 Dividend Income Tax Treatment
HASI Announces 2023 Dividend Income Tax Treatment
Hannon Armstrong Sustainable Infrastructure Capital, Inc. ("HASI" or the "Company") (NYSE: HASI), a leading investor in climate solutions, today announced the Federal income tax treatment of the Company’s 2023 distributions on its common stock (CUSIP #41068X100).
The Federal income tax classification of the aggregate $1.56 distribution per share on the Company's common stock with respect to the calendar year ended December 31, 2023, is shown in the table below:
Record Date |
Payable Date |
Total
|
Ordinary
|
Return of
|
Long-Term
|
Section
|
12/28/2022 |
01/06/2023 |
$0.3750 |
$0.1965 |
$0.0222 |
$0.1566 |
$0.1965 |
04/03/2023 |
04/10/2023 |
$0.3950 |
$0.2069 |
$0.0231 |
$0.1649 |
$0.2069 |
07/05/2023 |
07/12/2023 |
$0.3950 |
$0.2069 |
$0.0231 |
$0.1649 |
$0.2069 |
10/04/2023 |
10/11/2023 |
$0.3950 |
$0.2069 |
$0.0231 |
$0.1649 |
$0.2069 |
2023 |
Total |
$1.5600 |
$0.8172 |
$0.0915 |
$0.6513 |
$0.8172 |
12/29/2023 |
01/12/2024 |
|
To Be Reported on 2024 1099-Div |
|
The amount reported as Ordinary Income Per Share is treated as a qualified REIT dividend for purposes of Section 199A. As the Company's aggregate distributions exceeded its taxable earnings and profits, the January 2024 distribution declared in the fourth quarter of 2023 and payable to stockholders of record as of December 29, 2023, will be treated as a 2024 distribution for Federal income tax purposes and is not included on the 2023 Form 1099. Stockholders are encouraged to consult with their own tax advisors as to their specific tax treatment of the Company's distributions.
About HASI
HASI (NYSE: HASI) is a leading climate positive investment firm that actively partners with clients to deploy real assets that facilitate the energy transition. With more than $11 billion in managed assets, our vision is that every investment improves our climate future. For more information, please visit hasi.com.
Forward Looking Statements
Some of the information contained in this press release is forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended that are subject to risks and uncertainties. For these statements, we claim the protections of the safe harbor for forward-looking statements contained in such Sections. These forward-looking statements include information about possible or assumed future results of our business, financial condition, liquidity, results of operations, plans and objectives. When we use the words "believe," "expect," "anticipate," "estimate," "plan," "continue," "intend," "should," "may" or similar expressions, we intend to identify forward-looking statements.
Forward-looking statements are subject to significant risks and uncertainties. Investors are cautioned against placing undue reliance on such statements. Actual results may differ materially from those set forth in the forward-looking statements. Factors that could cause actual results to differ materially from those described in the forward-looking statements include those discussed under the caption “Risk Factors” included in our most recent Annual Report on Form 10-K as well as in other periodic reports that we file with the U.S. Securities and Exchange Commission (the "SEC").
Forward-looking statements are based on beliefs, assumptions and expectations as of the date of this press release. We disclaim any obligation to publicly release the results of any revisions to these forward-looking statements reflecting new estimates, events or circumstances after the date of this press release.
Investor Relations Inquiries:
Neha Gaddam
investors@hasi.com
410-571-6189
View source version on businesswire.com: https://www.businesswire.com/news/home/20240131518047/en/
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth